Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Sila Realty Trust Announces Fourth Quarter and Year Ended 2024 Results

In This Article:

TAMPA, Fla., February 25, 2025--(BUSINESS WIRE)--Sila Realty Trust, Inc. (NYSE: SILA) ("Sila", the "Company", "we", or "us"), a net lease real estate investment trust ("REIT") with a strategic focus on investing in the growing and resilient healthcare sector, today announced operating results for the fourth quarter and year ended December 31, 2024.

Highlights for the quarter ended December 31, 2024:

  • Net income of $11.1 million, or $0.20 per diluted share

  • Cash net operating income*, or Cash NOI, of $41.0 million

  • Adjusted funds from operations*, or AFFO, of $30.2 million, or $0.54 per diluted share

  • Paid cash distributions per share of $0.40 and declared cash distributions per share of $0.27 for the quarter

  • Changed the frequency of the distributions to stockholders from monthly distributions to quarterly distributions, effective in 2025, with the first quarterly distribution to be paid in the first fiscal quarter of 2025

  • Entered into two mezzanine loans for the development of an inpatient rehabilitation facility and a behavioral healthcare facility in Lynchburg, Virginia, with total loan amounts of $12.5 million and $5.0 million, respectively

  • Sold the Yucca Valley Healthcare Facility for a sales price of $1.7 million, generating net proceeds of $1.6 million

  • Entered into a new triple-net lease agreement, effective December 13, 2024, with the Regents of the University of California for the El Segundo Healthcare Facility, which was previously leased to GenesisCare USA, Inc. and its affiliates, or GenesisCare, for an initial 10-year term, subject to two consecutive 5-year renewal options exercisable by the tenant (subject to certain conditions)

  • Entered into 15 amended lease agreements, effective December 1, 2024, with certain subsidiaries of Post Acute Medical, LLC, or Post Acute Medical, related to 15 properties, extending the term of each lease to a 20-year remaining lease term, with each maturing on November 30, 2044, and no changes to the base rental rate

Highlights for the year ended December 31, 2024:

  • Net income of $42.7 million, or $0.75 per diluted share

  • Cash NOI of $168.6 million

  • AFFO of $131.1 million, or $2.31 per diluted share

  • Paid cash distributions per share of $1.60 and declared cash distributions per share of $1.47 for the year

  • Listed on the New York Stock Exchange on June 13, 2024

  • Concluded a modified "Dutch Auction" tender offer for an aggregate purchase price of approximately $50.0 million, excluding all related costs and fees

  • Purchased eight operating healthcare properties, comprising approximately 307,000 rentable square feet for an aggregate purchase price of approximately $164.1 million

  • Sold four healthcare facilities for an aggregate sale price of $18.7 million and generated net proceeds of $17.7 million